The role of palbociclib in thyroid carcinoma with BRAF mutation

Gland Surg. 2018 Aug;7(Suppl 1):S82-S85. doi: 10.21037/gs.2018.03.07.

Authors

Nikolaos Tsoukalas^{1

2}, Konstantinos Tsapakidis², Krystallenia I Alexandraki³

Affiliations

¹ Department of Oncology, Veterans Hospital (NIMTS), Athens, Greece.
² Department of Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.
³ Endocrine Unit, 1st Department of Propaedeutic Medicine, Laiko University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

No abstract available

Publication types

Editorial
Comment